Ethyl 2-chloropyrimidine-4-carboxylate, 95.0%, 25g

(6-(Benzyloxy)-5-methylpyridin-3-yl)boronic acid, 95.0%, 1g

1-(6-methoxypyridin-3-yl)-N-methylmethanamine dihydrochloride, 95.0%, 500mg

6-CHLOROBENZO[D]ISOXAZOL-3-AMINE, 95.0%, 5g

2-Cyclopentyl-2-phenylethan-1-amine, 95+%, 1g

5,6-Dihydro-4H-pyrrolo[1,2-b]pyrazole-3-carboxylic acid, 95.0%, 1g

1-Nitro-2-(phenylsulfonyl)benzene, 95.0%, 5g

1-Ethyl-1H-1,2,4-triazole, 97.0%, 25g

4-[4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]morpholine>98.0%(GC)5g

(2-Iodo-pyridin-4-yl)-carbamic acid tert-butyl ester, 97%, 1g

N-(Propargyl-PEG4-carbonyl)-N-bis(PEG1-methyl ester), 100mg

1-(1,2,3,4-Tetrahydroisoquinolin-6-yl)ethan-1-one, 97%, 1g

Nepsilon-(tert-Butoxycarbonyl)-Nalpha-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-lysine>98.0%(HPLC)(T)25g